Vascular endothelial senescence: from mechanisms to pathophysiology
- PMID: 19036896
- PMCID: PMC2636933
- DOI: 10.1152/japplphysiol.91353.2008
Vascular endothelial senescence: from mechanisms to pathophysiology
Abstract
Most mitotically competent mammalian cell types can react to stress by undergoing a phenotypically distinctive and permanent form of growth arrest called "cellular senescence." This response has been extensively characterized in cell culture and more recently it has been found to occur also in vivo in a number of tissues. In this review I will present the case for the occurrence of senescence in the vascular endothelium. I will also discuss the mechanisms and factors that modulate endothelial cell replicative capacity and the onset of senescence. Finally, I will examine the senescent phenotype and its possible consequences for the development and progression of vascular diseases.
Figures
References
-
- Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, Spyridopoulos I, Zeiher AM, Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92: 1049–1055, 2003. - PubMed
-
- Aviv H, Khan MY, Skurnick J, Okuda K, Kimura M, Gardner J, Priolo L, Aviv A. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 159: 281–287, 2001. - PubMed
-
- Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, aging. Cell 120: 483–495, 2005. - PubMed
-
- Borras C, Esteve JM, Vina JR, Sastre J, Vina J, Pallardo FV. Glutathione regulates telomerase activity in 3T3 fibroblasts. J Biol Chem 279: 34332–34335, 2004. - PubMed
-
- Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 493: 21–25, 2001. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
